Showing results (1941-1950 of 2,199) with videos related to

Sort By:
Pageof 220
Journal of Pediatric Gastroenterology and Nutrition|May 7, 2015
Role of Coping With Symptoms in Depression and Disability: Comparison Between Inflammatory Bowel Disease and Abdominal PainMiranda A L van Tilburg, Robyn L Claar, Joan M Romano, et al.
Npj Imaging|December 9, 2024
Robust self-supervised denoising of voltage imaging data using CellMincerBrice Wang, Tianle Ma, Theresa Chen, et al.
Environment International|March 15, 2022
Systematic review of wastewater surveillance of antimicrobial resistance in human populationsK K Chau, L Barker, E P Budgell, et al.
Antimicrobial Agents and Chemotherapy|April 28, 2010
Pharmacokinetics of lopinavir-ritonavir with and without nonnucleoside reverse transcriptase inhibitors in Ugandan HIV-infected adultsC Kityo, A S Walker, L Dickinson, et al.
Lancet (London, England)|November 24, 2004
Co-trimoxazole as prophylaxis against opportunistic infections in HIV-infected Zambian children (CHAP): a double-blind randomised placebo-controlled trialC Chintu, G J Bhat, A S Walker, et al.
Journal of Affective Disorders|January 21, 2023
Prevalence of depression and anxiety in older people in low- and middle- income countries in Africa, Asia and South America: A systematic review and meta-analysisN Edwards, S Walker, S-M Paddick, et al.
Journal of Surgical Oncology|May 6, 2022
Hepatic arterial infusion pump chemotherapy combined with systemic therapy for patients with advanced colorectal liver metastases: Outcomes in a newly established programBrett S Walker, Kevin G Billingsley, Thomas L Sutton, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|May 31, 2012
Selective mechanism-based inactivation of CYP3A4 by CYP3cide (PF-04981517) and its utility as an in vitro tool for delineating the relative roles of CYP3A4 versus CYP3A5 in the metabolism of drugsRobert L Walsky, R Scott Obach, Ruth Hyland, et al.
Neurology|October 21, 2011
PRION-1 scales analysis supports use of functional outcome measures in prion diseaseS Mead, M Ranopa, G S Gopalakrishnan, et al.
Clinical Lung Cancer|August 6, 2013
Prospective observational comparison of clinical outcomes between african-american and caucasian patients receiving second-line treatment with pemetrexed for advanced non-small-cell lung cancerEduardo Pennella, Coleman K Obasaju, Gerhardt Pohl, et al.
Pageof 220